【更正】9/17MRD研討會改以hybrid (實體會議+視訊)進行，受限於場地限制，實體會場限額50名，額滿即截止報名，欲報從速。
(1)實體(會議地點：台中日月千禧 B2 宴會廳2)：限額50人，請會員填下面表單，透過網路報名，恕不受理e-mail或電話或傳真報名。將以網路報名先後順序，錄取前50位報名者，額滿即截止報名，欲報從速。
(2)視訊報名連結：https://www.pharmedia.com.tw/abbvie/20220917_MRD_Symposium2.pdf
教育積分：中華民國血液病學會甲類2.5分、中華民國血液及骨髓移植學會1分、台灣癌症安寧緩和醫學會2分、中華民國癌症醫學會腫瘤內科A類1分。
參加實體會議，有事先報名及親自帶身分證到場刷卡報到者，可獲取教育學分。線上參與超過75分鐘，亦可獲取教育積分。

Time	Topic	Chairman
13:30-13:35	Welcome and introduction	Prof Wen-Chien Chou
Acute Myeloid Leukemia session:		Session Chair: Prof YL Kwong / Prof Hsin-An Hou
13:35-13:45	Clinical application of MRD monitoring in HK	Dr Harry Gill
13:45-13:55	MRD application in HK, the pathology perspective	Dr Alvin Ip
13:55-14:05	Clinical application of NGS MRD monitoring in Taiwan	Dr Cheng-Hong Tsai
14:05-14:15	Clinical application of MRD monitoring by flow and Q-PCR in Taiwan	Dr Chi-Yuan Yao
14:15-14:45	Panel discussion	Prof YL Kwong / Prof Hsin-An Hou
14:45-14:55	Break
Chronic Lymphoid Leukemia session:		Session Chair: Prof Eric Tse / Dr Tran-Der Tan
14:55-15:05	Clinical application of MRD monitoring in HK	Dr Thomas Chan
15:05-15:15	MRD application in HK, the pathology perspective	Dr Rock Leung
15:15-15:35	Clinical application of MRD monitoring in Taiwan	Dr Wei-Han Huang
15:35-16:05	Panel discussion	Prof Eric Tse / Dr Tran-Der Tan
16:05-16:15	Look into future of MRD in HK & Taiwan	Prof Hsin-An Hou